Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 33581875)

  • 1. Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.
    Catto JWF; Downing A; Mason S; Wright P; Absolom K; Bottomley S; Hounsome L; Hussain S; Varughese M; Raw C; Kelly P; Glaser AW
    Eur Urol; 2021 May; 79(5):621-632. PubMed ID: 33581875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first year.
    Rogers Z; Glaser A; Catto JWF; Bottomley S; Jubber I; Kotwal S; Brittain P; Gill J; Rogers MA; Dooldeniya MD; Koenig P; Cresswell J; Chahal R; Bryan N; Smith NJ; Pritchard K; Abbasi Z; Mason SJ; Absolom K; Downing A
    BJU Int; 2024 Apr; 133(4):460-473. PubMed ID: 38031657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual Activity, Function and Dysfunction After a Diagnosis of Bladder Cancer.
    Jubber I; Rogers Z; Catto JW; Bottomley S; Glaser A; Downing A; Absolom K
    J Sex Med; 2022 Sep; 19(9):1431-1441. PubMed ID: 35871051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients.
    Venderbos LDF; Deschamps A; Dowling J; Carl EG; Remmers S; van Poppel H; Roobol MJ
    Eur Urol Focus; 2021 Sep; 7(5):987-994. PubMed ID: 33281109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
    Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
    Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.
    Downing A; Wright P; Hounsome L; Selby P; Wilding S; Watson E; Wagland R; Kind P; Donnelly DW; Butcher H; Catto JWF; Cross W; Mason M; Sharp L; Weller D; Velikova G; McCaughan E; Mottram R; Allen M; Kearney T; McSorley O; Huws DW; Brewster DH; McNair E; Gavin A; Glaser AW
    Lancet Oncol; 2019 Mar; 20(3):436-447. PubMed ID: 30713036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
    Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
    BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study.
    Brusniak K; Feisst M; Sebesteny L; Hartkopf A; Graf J; Engler T; Schneeweiss A; Wallwiener M; Deutsch TM
    JMIR Cancer; 2021 Oct; 7(4):e25776. PubMed ID: 34636732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.
    Kretschmer A; Grimm T; Buchner A; Jokisch F; Ziegelmüller B; Casuscelli J; Schulz G; Stief CG; Karl A
    Eur Urol Focus; 2020 Jul; 6(4):704-710. PubMed ID: 30853603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
    Westhofen T; Eismann L; Buchner A; Schlenker B; Giessen-Jung C; Becker A; Stief CG; Kretschmer A
    Eur Urol Focus; 2022 Nov; 8(6):1659-1665. PubMed ID: 35184991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after.
    Miret C; Orive M; Sala M; García-Gutiérrez S; Sarasqueta C; Legarreta MJ; Redondo M; Rivero A; Castells X; Quintana JM; Garin O; Ferrer M;
    Qual Life Res; 2023 Apr; 32(4):989-1003. PubMed ID: 36630024
    [TBL] [Abstract][Full Text] [Related]  

    Efthymiadou O; Mossman J; Kanavos P
    Int J Technol Assess Health Care; 2018 Jan; 34(5):498-506. PubMed ID: 30251618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life of Cancer Patients during Chemotherapy in Indonesia: A Comparison of EORTC QLQ-C30 and EQ-5D-5L, Based on Patients' Characteristics.
    Perwitasari DA; Purba FD; Candradewi SF; Dania H; Muhammad Irham L; Noor Faridah I; Septiantoro BP
    Int J Clin Pract; 2023; 2023():9357299. PubMed ID: 36908296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort.
    Beeren I; Klerks NE; Aben KK; Oddens JR; Witjes JA; Kiemeney LA; Vrieling A
    Eur Urol Oncol; 2023 Nov; ():. PubMed ID: 37996278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.
    Lloyd AJ; Kerr C; Penton J; Knerer G
    Value Health; 2015 Dec; 18(8):1152-7. PubMed ID: 26686802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
    Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related Quality of Life with Adjuvant Nivolumab After Radical Resection for High-risk Muscle-invasive Urothelial Carcinoma: Results from the Phase 3 CheckMate 274 Trial.
    Witjes JA; Galsky MD; Gschwend JE; Broughton E; Braverman J; Nasroulah F; Maira-Arce M; Ye X; Shi L; Guo S; Hamilton M; Bajorin DF
    Eur Urol Oncol; 2022 Oct; 5(5):553-563. PubMed ID: 35288066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
    Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
    Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health related quality of life in patients with bladder cancer: a cross-sectional survey and validation study of the Hungarian version of the Bladder Cancer Index.
    Hevér NV; Péntek M; Balló A; Gulácsi L; Baji P; Brodszky V; Damásdi M; Bognár Z; Tóth G; Buzogány I; Szántó Á
    Pathol Oncol Res; 2015 Jul; 21(3):619-27. PubMed ID: 25434791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.